NeuroSense Therapeutics Ltd (NRSN) insider trading
Every open-market stock purchase and sale by NeuroSense Therapeutics Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $400K over the last 12 months (2 buys).
- Last insider buy: Alon Ben-Noon (CEO), $200K, 4 months ago.
Last 12 months: insiders bought $400K (2 buys) and sold $0 (0 sales).
Recent NRSN insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 16, 2026 | Alon Ben-Noon (CEO) | Bought | $200K |
| Jun 16, 2026 | Or Eisenberg (CFO) | Bought | $200K |
| Mar 26, 2026 | Hagit Binder (Officer) | Bought (not open market) | — |
| Mar 26, 2026 | Niva Russek-Blum (CTO) | Bought (not open market) | — |
| Mar 26, 2026 | Or Eisenberg (CFO) | Bought (not open market) | — |
Who's trading NRSN
- Alon Ben-Noon, CEO: bought $200K (1 buy), last Jun 16, 2026
- Or Eisenberg, CFO: bought $200K (1 buy), last Jun 16, 2026
- Hagit Binder, Officer: other filings, last Mar 26, 2026
- Niva Russek-Blum, CTO: other filings, last Mar 26, 2026
Get free alerts when an insider at NeuroSense Therapeutics Ltd files a new trade →